MUSCLE RELAXANTS. Mr. D.Raju, M.pharm, Lecturer

Size: px
Start display at page:

Download "MUSCLE RELAXANTS. Mr. D.Raju, M.pharm, Lecturer"

Transcription

1 MUSCLE RELAXANTS Mr. D.Raju, M.pharm, Lecturer

2 Muscle Relaxants are classified as: I)Peripherally acting A.Neuromuscular blocking agents:- 1) Depolarizing muscle relaxants. 2) Non-depolarizing muscle relaxants B.) Directly acting: Dantrolene, Quinine II)Centrally acting o Chlorzoxazone,Chlormezanone, Diazepam, Baclofen, Tizanidine, Metaxalone.

3 Depolarizing Muscle relaxants: Succinylcholine (short acting) Non-depolarizing Muscle relaxants: Short acting: Mivacurium Intermediate acting: Atracurium, Cisatracurium, Vecuronium, Rocuronium Long acting : Doxacurium Pancuronium Pipecuronium

4 MECHANISM OF ACTION SUXAMETHONIUM: Block transmission by causing prolonged depolarization of endplate at neuromuscular junction. Manifestation by initial series of muscle twitches (fasciculation) followed by flaccid paralysis. It immediately metabolize in plasma by Pseudocholinesterase which is synthesized by liver so to prevent its metabolism in plasma it should be given at faster rate.

5 SYSTEMIC EFFECTS Cardiovascular: Produces muscarinic effects as acetylcholine, therefore causes bradycardia ( but when given high doses causes tachycardia because of stimulation of nicotinic receptors at sympathetic ganglions.) Hyperkalemia: Occurs due to excessive muscle fasciculations. Ventricular fibrillation can occur due to hyperkalemia. CNS: Increases intracranial tension ( due to contraction of neck vessels) Eye: Increases intraocular pressure.

6 GIT: Increases intra-gastric pressure, salivation, peristalsis. Muscle pains ( myalgia): This is a very common problem in post operative period. These are due to excessive muscle contractions. Malignant hyperthermia Severe Anaphylaxis Masseter Spasm : Sch can cause masseter spasm especially in children & patients susceptible for malignant hyperthermia. Doesnot require reversal rather cholinesterase inhibitors (neostigmine) can prolong the depolarizing block (because these agents also inhibits the pseudocholinesterase)

7 CONTRAINDICATIONS Hyperkalemia: Serum K > 5.5 is an absolute contraindication for use of Sch. Head Injury : It increase ICP Newborns and infants: These have extrajunctional receptors which are sensitive to depolarizing agents & Sch can produce severe hyperkalemia by interacting with these receptors. Glaucoma & eye injuries. Up to 2-3 months after trauma, Up to 6 months after hemiplegia/paraplegia, Up to 1

8 Renal Failure : If associated with hyperkalemia. Prolonged intra abdominal infection can be associated with hyperkalemia. Diagnosed case of atypical pseudocholinesterase & low pseudocholinesterase. Duchene muscular dystrophy Dystrophia myotonica: Permanent contractures may develop if SCh is given in these patients. Tetanus. Gullian Barre Syndrome Metabolic Acidosis :Acidosis is associated with hyperkalemia. Shock : It is associated with acidosis which in turn is associated with hyperkalemia. Spinal cord injury.

9 NON-DEPOLARIZING MUSCLE RELAXANTS: Mechanism of action: It blocks nicotinic receptors competitively resulting in inhibition of sodium channels and excitatory post-synaptic potential. It binds at the same site at which acetylcholine binds. All NDMR are quarternary ammonium compounds & highly water soluble i.e. hydrophilic. So, they do not cross blood brain barrier & placenta except Gallamine.

10 BROAD CLASSIFICATION These are broadly divided into steroidal compounds and benzylisoquinoline (BZIQ) compunds. STEROIDAL COMPOUNS: (vagolytic properties) It includes PANCURONIUM,VECURONIUM, PIPECURONIUM,ROCURONIUM, RAPACURONIUM. BZIQ(Benzylisoquinoline): (hystamine realease) It includes d-tubocurare, Metocurine, Doxacurium, Atracurium, Mivacurium,

11 STEROIDAL COMPOUNDS Pancuronium(PAVULON) Very commonly used as it is inexpensive. It releases noradrenaline & can cause tachycardia & hypertension. Because of this there are increased chances of arrhythmia with halothane Pipercuronium It is a pancuronium derivative with no vagolytic activity, so cardiovascular stable, slightly more potent Vercuronium (Norcuron) It is very commonly used now a days. It is cardiovascular stable. Shorter duration of action. It is the muscle relaxant of choice in cardiac patient. Rocuronium 8 times more potent than vecuronium and it also has earlier onset of action Because of onset comparable to succinylcholine it is suitable for rapid sequence intubation as an alternative to succinylcholine.

12 BENZYLISOQUINOLINE COMPOUNDS D- Tubocurare It is named so because it was carried in bamboo tubes & used as arrow poison for hunting by Amazon people. It has highest propensity to release histamine It causes maximum ganglion blockade. Because of ganglion blocking & histamine releasing property it can produce severe hypotension.

13 CENTRALLY ACTING MUSCLE RELAXANTS These are drugs which produce muscle relaxation through central mechanism both at supraspinal & spinal level Polysynaptic reflexes involved in maintenance of muscle tone are inhibited at both spinal & supraspinal level. It also produces sedation Uses Muscle spasms. Tetanus : IV diazepam is most effective. Spastic neurological diseases like cerebral

14 REVERSAL OF BLOCK Drugs used for reversal of block are cholinesterase inhibitors (anticholinesterases). Reversal should be given only after some evidence of spontaneous recovery appear. Mechanism of Action It inactivate the enzyme acetylcholinesterase which is responsible for break down of actetylcholine, thus increasing the amount of acetylcholine available for competition with non depolarizing agent thereby re-establishing neuromuscular transmission. Anticholinesterases used for reversal are: Neostigmine Pyridostigmine Edrophonium Physostigmine

15 These agents except physostigmine are quarternary ammonium compounds so they do not cross blood brain barrier. The biggest disadvantage is that these agents also increase the acetylcholine level at muscarinic receptors producing muscarinic side effects like bradycardia, bronchospasm. So, to prevent these muscarinic effects some anti cholinergic like atropine or glycopyrrolate is to be given with cholinesterase inhibitors. Neostigmine : Anticholinergic preferred with it is glycopyrrolate because both have same onset of action (both are slow acting). Edrophonium : Anticholinergic preferred with it is atropine (both fast acting). Pyridostigmine: It is preferred drug for renal failure patients in whom a prolonged stay of muscle relaxant is expected.

16 DRUGS WHICH ANTAGONISE NEUROMUSCULAR BLOCKADE They reverse the block by NDMR only Phenytoin Carbamazepine Calcium Cholinesterase inhibitors Azathioprine Steroids.

NERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system

NERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system SYNAPTIC NERVOUS SYSTEM NERVOUS SYSTEM CENTRAL NERVOUS SYSTEM PERIPHERAL NERVOUS SYSTEM Brain Spinal Cord Autonomic nervous system Somatic nervous system Sympathetic nervous system Parasympathetic nervous

More information

Benztropine and trihexyphenidyl: Centrally acting antimuscarinic agents used for treatment of Parkinson disease & extrapyramidal symptoms.

Benztropine and trihexyphenidyl: Centrally acting antimuscarinic agents used for treatment of Parkinson disease & extrapyramidal symptoms. Scopolamine: Tertiary amine plant alkaloid. Produces peripheral effects similar to those of atropine. Unlike atropine, scopolamine has greater action on the CNS (observed at therapeutic doses). It has

More information

NEUROMUSCULAR BLOCKING AGENTS

NEUROMUSCULAR BLOCKING AGENTS NEUROMUSCULAR BLOCKING AGENTS Edward JN Ishac, Ph.D. Associate Professor, Pharmacology and Toxicology Smith 742, 828-2127, Email: eishac@vcu.edu Learning Objectives: 1. Understand the physiology of the

More information

Chapter 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)

Chapter 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) Chapter 18 Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) Uses of Neuromuscular Blocking Facilitate intubation Surgery Agents Enhance ventilator synchrony Reduce intracranial pressure (ICP)

More information

Pharmacology of the Neuromuscular Junction (NMJ)

Pharmacology of the Neuromuscular Junction (NMJ) Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia

More information

Neuromuscular Blockers

Neuromuscular Blockers Neuromuscular Blockers Joanne Leung joanneleung22@hotmail.com Oct 14, 2014 Objectives After this lecture, you should be able to: Describe the physiology of the neuromuscular junction Differentiate the

More information

Pharmacology of the Neuromuscular Junction (NMJ)

Pharmacology of the Neuromuscular Junction (NMJ) Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia

More information

Ganglion blocking agents

Ganglion blocking agents Ganglion blocking agents -out of date -Specifically act on the nicotinic receptors of both parasymphatetic and sympathetic ganglia - no selectivity toward PG or SG -These drugs are non-depolarizing, competitive

More information

(PP XI) Dr. Samir Matloob

(PP XI) Dr. Samir Matloob DRUGS ACTING ON THE CHOLINERGIC SYSTEM AND THE NEUROMUSCULAR BLOCKING DRUGS IV (NICOTINIC ANTAGONISTS) (PP XI) Dr. Samir Matloob Dept. of Pharmacology Baghdad College of Medicine Drugs acting on the cholinergic

More information

Neuromuscular Junction

Neuromuscular Junction Muscle Relaxants Neuromuscular Junction Cholinergic antagonists Neuromuscular-blocking agents (mostly nicotinic antagonists): interfere with transmission of efferent impulses to skeletal muscles. These

More information

Chapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise

Chapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise Chapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise 1. Read chapter 2. Review objectives (p.305) 3. Review key terms and definitions (p.305) Add: Cholinesterase inhibitor Vagal

More information

Cholinergic antagonists

Cholinergic antagonists Cholinergic antagonists Cholinergic antagonists: They are also called anticholinergic drugs or cholinergic blockers, this group include: 1.Antimuscarinic agents ( atropine, ipratropium, scopolamine) 2.

More information

The Latest Approaches to Reversal of Neuromuscular Blocking Agents

The Latest Approaches to Reversal of Neuromuscular Blocking Agents The Latest Approaches to Reversal of Neuromuscular Blocking Agents Janay Bailey, Pharm.D. Anesthesiology 2017; 126:173-90 Objectives Pharmacists Determine optimal paralytic choices in knowing if reversal

More information

Nervous System. Peripheral Nervous System ( PNS ) Central Nervous System ( CNS ) Somatic. Autonomic ( ANS ) Enteric.

Nervous System. Peripheral Nervous System ( PNS ) Central Nervous System ( CNS ) Somatic. Autonomic ( ANS ) Enteric. NERVOUS SYSTEM Nervous System Peripheral Nervous System ( PNS ) Central Nervous System ( CNS ) Efferent (Motor) Afferent (Sensor) Autonomic ( ANS ) Somatic Parasympathetic Sympathetic Enteric Autonomic

More information

Skeletal Muscle Relaxants. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014

Skeletal Muscle Relaxants. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014 Skeletal Muscle Relaxants Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014 The nicotinic Acetycholine receptor Present at the neuromuscular junction, peripheral

More information

BIMM118. Autonomic Nervous System

BIMM118. Autonomic Nervous System Autonomic Nervous System Autonomic Nervous System Autonomic Nervous System Ganglia close to the innervated organs Myelinated axons Ganglia close to the spinal column Preganglionic axons are myelinated;

More information

LESSON ASSIGNMENT. LESSON OBJECTIVES 3-1. Given a group of definitions, select the definition of the term muscle relaxant.

LESSON ASSIGNMENT. LESSON OBJECTIVES 3-1. Given a group of definitions, select the definition of the term muscle relaxant. LESSON ASSIGNMENT LESSON 3 Skeletal Muscle Relaxants. TEXT ASSIGNMENT Paragraphs 3-1 through 3-7. LESSON OBJECTIVES 3-1. Given a group of definitions, select the definition of the term muscle relaxant.

More information

Pharmacology of neuromuscular blocking drugs

Pharmacology of neuromuscular blocking drugs Pharmacology of neuromuscular blocking drugs Jonas Appiah-Ankam MB ChB FRCA Jennifer M Hunter MB ChB PhD FRCA Key points Neuromuscular blocking drugs (NMBDs) act at several sites at the neuromuscular junction,

More information

Skeletal Muscle Relaxants

Skeletal Muscle Relaxants 12 Skeletal Muscle Relaxants Neuromuscular blocking drugs Depolarizing Nondepolarizing MAJR DRUG CLASSES Antispasticity drugs Antispasm drugs Motor nerve blockers ACh AChE CNS GABA Abbreviations Acetylcholine

More information

Pharmacological Inhibition of skeletal muscle activity

Pharmacological Inhibition of skeletal muscle activity Pharmacological Inhibition of skeletal muscle activity By actions at different anatomical/physiological sites, such as CNS by general anaesthetics Spinal cord - by acting on spinal motor control mechanisms

More information

Ganglionic Blocking Agents

Ganglionic Blocking Agents Ganglionic Blocking Agents 1- Depolarizing Ganglionic Blocking Agents Depolarizing blocking agents are actually ganglionic stimulants. Thus, for nicotine, small doses give an action similar to that of

More information

Anesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists. Upon completion of this activity, participants will be better able to:

Anesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists. Upon completion of this activity, participants will be better able to: Anesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Understand the use of neuromuscular

More information

Joseph F. Answine, MD

Joseph F. Answine, MD Joseph F. Answine, MD Joseph F. Answine, MD Staff Anesthesiologist Pinnacle Health Hospitals Harrisburg, PA Clinical Associate Professor of Anesthesiology Pennsylvania State University Hospital Reversal

More information

Cholinergic receptors( cholinoceptors ) are two families muscarinic and nicotinic depending on their affinities to cholinomimetic agents(agents that

Cholinergic receptors( cholinoceptors ) are two families muscarinic and nicotinic depending on their affinities to cholinomimetic agents(agents that Cholinergic drugs Cholinergic drugs Are drugs act on receptors that are activated by acetylcholine(ach) which is the neurotransmitter of the parasympathetic nervous system. ACH is synthesized in the cholinergic

More information

Drugs Affecting the Autonomic Nervous System-2 Cholinergic agents

Drugs Affecting the Autonomic Nervous System-2 Cholinergic agents Drugs Affecting the Autonomic Nervous System-2 Cholinergic agents Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Cholinergic agents, Cholinomimetic drugs,

More information

BIOP211 Pharmacology Tutorial Session 10 Drugs affecting the PNS

BIOP211 Pharmacology Tutorial Session 10 Drugs affecting the PNS BIOP211 Pharmacology Tutorial Session 10 Drugs affecting the PNS Students problem-solve case studies of given drug scenarios affecting the peripheral nervous system Students continue to work on the Drug

More information

CHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A

CHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A CHAPTER 11 General and Local Anesthetics Eliza Rivera-Mitu, RN, MSN NDEG 26 A Anesthetics Agents that depress the central nervous system (CNS) Depression of consciousness Loss of responsiveness to sensory

More information

Has little therapeutic value. Has multiple actions. Has short t ½ Activates muscarinic & nicotinic receptors. 10/17/2017 2

Has little therapeutic value. Has multiple actions. Has short t ½ Activates muscarinic & nicotinic receptors. 10/17/2017 2 Has little therapeutic value. Has multiple actions. Has short t ½ Activates muscarinic & nicotinic receptors. 10/17/2017 2 Muscarinic stimulation: On the CVS: -ve chronotropic & inotropic effects. Decrease

More information

Suxamethonium Chloride Injection BP PRODUCT INFORMATION

Suxamethonium Chloride Injection BP PRODUCT INFORMATION Suxamethonium Chloride Injection BP Product Information 1 (8) Suxamethonium Chloride Injection BP PRODUCT INFORMATION NAME OF DRUG The Australian Approved Name is suxamethonium chloride. The CAS number

More information

Parasympathetic Nervous System Part I

Parasympathetic Nervous System Part I Parasympathetic Nervous System Part I Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia Campus of Virginia

More information

ANTICHOLINERGIC DRUGS

ANTICHOLINERGIC DRUGS ANTICHOLINERGIC DRUGS ANTICHOLINERGIC DRUGS (Muscarinic Receptor Antagonist, Parasympatholytics, Cholinolytics Atropine-like Drugs) Atropine, the prototype drug of this class, is a highly selective blocking

More information

A Successful RSI Program

A Successful RSI Program RSI A Successful RSI Program Requires understanding of: Indications Contraindications Limitations Requires knowledge of: Physiology Pharmacology Airway techniques Goals of RSI Success rates comparable

More information

number Done by Corrected by Doctor Malik

number Done by Corrected by Doctor Malik number 21 Done by Corrected by Dania Alkouz Doctor Malik Dr. Malik is going to repeat what Dr. Omar said about the cholinergic agonists and antagonists. The Autonomic Nervous system (ANS) (Just a quick

More information

Pharmacology Autonomic Nervous System Lecture10

Pharmacology Autonomic Nervous System Lecture10 Pharmacology Autonomic Nervous System Lecture10 Note : Most of the time in this lecture, the doctor was only reading from the slides, so I m going to write only the extra information he mentioned So Please

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET NEW ZEALAND DATA SHEET 1. PRODUCT NAME SUXAMETHONIUM CHLORIDE INJECTION B.P. 50 mg/ml 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2 ml of solution contains 100 mg of suxamethonium chloride BP For

More information

Core Safety Profile. Pharmaceutical form(s)/strength: Solution for Injection CZ/H/PSUR/0005/002 Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: Solution for Injection CZ/H/PSUR/0005/002 Date of FAR: Core Safety Profile Active substance: Rocuronium bromide Pharmaceutical form(s)/strength: Solution for Injection P-RMS: CZ/H/PSUR/0005/002 Date of FAR: 31.05.2012 4.3 Contraindications Hypersensitivity

More information

Quelicin TM SUCCINYLCHOLINE CHLORIDE INJECTION, USP

Quelicin TM SUCCINYLCHOLINE CHLORIDE INJECTION, USP Quelicin TM SUCCINYLCHOLINE CHLORIDE INJECTION, USP A short-acting depolarizing skeletal muscle relaxant. Fliptop Vial Rx only WARNING RISK OF CARDIAC ARREST FROM HYPERKALEMIC RHABDOMYOLYSIS There have

More information

Succinycholine: Succinylcholine has no place in pediatric anesthesia. Wads Ames MBBS FRCA

Succinycholine: Succinylcholine has no place in pediatric anesthesia. Wads Ames MBBS FRCA Succinycholine: Succinylcholine has no place in pediatric anesthesia Wads Ames MBBS FRCA Food And Drug Administration Created in 1906 Responsible for protecting and promoting public health through the

More information

NEW ZEALAND DATA SHEET. Injection solution 2.5 mg/ml: a clear, colourless, particle-free solution containing 2.5 mg/ml Neostigmine methylsulphate.

NEW ZEALAND DATA SHEET. Injection solution 2.5 mg/ml: a clear, colourless, particle-free solution containing 2.5 mg/ml Neostigmine methylsulphate. NEW ZEALAND DATA SHEET NAME OF MEDICINE NEOSTIGMINE METHYLSULPHATE INJECTION B.P. Solution for injection 2.5 mg/ml. PRESENTATIONS Injection solution 2.5 mg/ml: a clear, colourless, particle-free solution

More information

Chapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications

Chapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications Chapter 13 Poisonings, Overdoses, and Intoxications Learning Objectives Discuss use of activated charcoal in treatment of poisonings List treatment options for acetaminophen overdose List clinical manifestations

More information

Effect of Vecuronium in different age group

Effect of Vecuronium in different age group Original Research Article Effect of Vecuronium in different age group Bharti Rajani 1, Hitesh Brahmbhatt 2, Hemlata Chaudhry 2, Hiren Parmar 3* 1 Associate Professor, Department of Anesthesiology, GMERS

More information

PRESCRIBING INFORMATION QUELICIN. Neuromuscular Blocking Agent

PRESCRIBING INFORMATION QUELICIN. Neuromuscular Blocking Agent PRESCRIBING INFORMATION QUELICIN Succinylcholine Chloride Injection USP Neuromuscular Blocking Agent Pfizer Canada Inc. 17300 Trans-Canada Highway Kirkland, Québec H9J 2M5 DATE OF REVISION: June 23, 2017

More information

Disclosure Statement:

Disclosure Statement: Quite possibly the most interesting drug NOT approved by the FDA Yet. Sal J Morana RPh, PhD Chief Operating Officer (formerly the Pharmacy Director) Porter Medical Center Middlebury, VT Adjunct Faculty/Preceptor

More information

Skeletal muscle relaxants

Skeletal muscle relaxants Slide #2+3+4+5: Revision for the Physiology of skeletal muscles: --Acetylcholine (Ach) works as a neurotransmitter for both the Sympathetic &Parasympathetic Systems. -- The Sympathetic system, at the synapses

More information

ANESTHESIA DRUG REVIEW

ANESTHESIA DRUG REVIEW ANESTHESIA REVIEW CAPA S 39 TH ANNUAL CONFERENCE PALM SPRINGS OCTOBER 10, 2015 ROBERT F. KOPEL, MD, FACP, FCCP HOAG HOSPITAL CARDIAC ANESTHESIOLOGIST ASSISTANT CLINICAL PROFESSOR UCLA SCHOOL OF MEDICINE

More information

PRODUCT MONOGRAPH. Edrophonium Chloride Injection, USP. 10 mg/ml. Nondepolarizing Neuromuscular Antagonist

PRODUCT MONOGRAPH. Edrophonium Chloride Injection, USP. 10 mg/ml. Nondepolarizing Neuromuscular Antagonist PRODUCT MONOGRAPH Pr TENSILON Edrophonium Chloride Injection, USP 10 mg/ml Nondepolarizing Neuromuscular Antagonist Valeant Canada LP 2150 St-Elzear Blvd., West Laval, Quebec H7L 4A8 Canada Date of Preparation:

More information

Ganglionic Blockers. Ganglion- blocking agents competitively block the action of

Ganglionic Blockers. Ganglion- blocking agents competitively block the action of Ganglionic Blockers Ganglion- blocking agents competitively block the action of acetylcholine and similar agonists at nicotinic (Nn) receptors of both parasympathetic and sympathetic autonomic ganglia.

More information

Autonomic Pharmacology: Cholinergic agonists

Autonomic Pharmacology: Cholinergic agonists Autonomic Pharmacology: Cholinergic agonists Öner Süzer www.onersuzer.com osuzer@istanbul.edu.tr Last update: 23.01.2013 1 Acetylcholine Acetylcholine (ACh), the naturally occurring neurotransmitter for

More information

RMP section VI.2 Elements for Public Summary

RMP section VI.2 Elements for Public Summary RMP section VI.2 Elements for Public Summary Product: Atropin Stragen, 0,1 mg/ml solution for injection in pre-filled syringe Atropin Stragen, 0,2 mg/ml solution for injection in pre-filled syringe RMP:

More information

Pain: 1-2µg/kg q30-60min prn. effects in 10 minutes. Contraindications: Morphine is preferred in. Duration of Action: minutes. renal failure.

Pain: 1-2µg/kg q30-60min prn. effects in 10 minutes. Contraindications: Morphine is preferred in. Duration of Action: minutes. renal failure. Procedural Sedation / Analgesia / Anaesthesia Chart - Page 1 Diazepam (Valium) Anxiolytic / Sedative Etomidate (Amidate) Hypnotic / Anesthetic Fentanyl Citrate (Sublimaze) Narcotic Analgesic Dose Pediatric:

More information

PRODUCT INFORMATION. TRACRIUM INJECTION atracurium besylate DESCRIPTION:

PRODUCT INFORMATION. TRACRIUM INJECTION atracurium besylate DESCRIPTION: PRODUCT INFORMATION TRACRIUM INJECTION (atracurium besylate) NAME OF THE DRUG: atracurium besylate DESCRIPTION: TRACRIUM (atracurium besylate) is an intermediate-duration, non-depolarising, skeletal muscle

More information

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT ACURMIL 25 mg/2.5 ml solution for intravenous injection ACURMIL 50 mg/5 ml solution for intravenous injection 2. QUALITATIVE AND QUANTITATIVE

More information

TRACRIUM GlaxoSmithKline

TRACRIUM GlaxoSmithKline TRACRIUM GlaxoSmithKline Atracurium QUALITATIVE AND QUANTITATIVE COMPOSITION Injection: A sterile solution containing 10 mg atracurium besylate per ml, without an antimicrobial preservative, supplied in

More information

NEW ZEALAND DATA SHEET. Injection 2 mg/ml: a clear, colourless, particle-free solution containing 2 mg/ml pancuronium bromide.

NEW ZEALAND DATA SHEET. Injection 2 mg/ml: a clear, colourless, particle-free solution containing 2 mg/ml pancuronium bromide. NEW ZEALAND DATA SHEET NAME OF MEDICINE Pancuronium Bromide B.P. Injection 2 mg/ml PRESENTATION Injection 2 mg/ml: a clear, colourless, particle-free solution containing 2 mg/ml pancuronium bromide. INDICATIONS

More information

The Neuromuscular Junction: Pharmacologic Applications During Anesthesia

The Neuromuscular Junction: Pharmacologic Applications During Anesthesia Page 1 The Neuromuscular Junction: Pharmacologic Applications During Anesthesia Cynthia A. Lien, M.D. New York, NewYork Introduction The neuromuscular junction and neuromuscular transmission are well-studied

More information

Neuromuscular Blockers

Neuromuscular Blockers HISTORY curare was used for many years by South American Indians as arrow poison West in 1932 used purified fractions of curare in patients with tetanus & spastic disorders used by Bennett in 1940 as an

More information

Suggamadex. Suggamadex. Suggamadex 4/28/2015. Goals: By the End of this Lecture, the Participant should be able to:

Suggamadex. Suggamadex. Suggamadex 4/28/2015. Goals: By the End of this Lecture, the Participant should be able to: Presented April, 2015 - OOA Convention by Ronald S. Stevens DO Board Certified Anesthesiologist Member Board of Trustees, OOA President/CEO Green Country Anesthesiology Associates PC. Conflict of Interest

More information

What is MH? Malignant Hyperthermia (MH)! Malignant Hyperthermia (MH) Malignant Hyperthermia (MH) ! The underlying physical mechanismintracellular

What is MH? Malignant Hyperthermia (MH)! Malignant Hyperthermia (MH) Malignant Hyperthermia (MH) ! The underlying physical mechanismintracellular 10/2/13 What is MH? Libby Morse BSN RN CPAN An inherited disorder of skeletal muscle triggered in susceptible humans in most instances by inhalation agents and/ or succinylcholine, resulting in hypermetabolism,

More information

PROSTIGMIN (neostigmine bromide)

PROSTIGMIN (neostigmine bromide) PROSTIGMIN (neostigmine bromide) TABLETS DESCRIPTION: Prostigmin (neostigmine bromide), an anticholinesterase agent, is available for oral administration in 15 mg tablets. Each tablet also contains gelatin,

More information

Nervous System Divisions

Nervous System Divisions Nervous System Divisions AFFERENT EFFERENT Objectives: To discuss the physiology of parasympathetic system To discuss the parasympathomimetic drugs both synthetic & natural,direct and indirect. To discuss

More information

Integrated Cardiopulmonary Pharmacology Third Edition

Integrated Cardiopulmonary Pharmacology Third Edition Integrated Cardiopulmonary Pharmacology Third Edition Chapter 3 Pharmacology of the Autonomic Nervous System Multimedia Directory Slide 19 Slide 37 Slide 38 Slide 39 Slide 40 Slide 41 Slide 42 Slide 43

More information

TRANSPARENCY COMMITTEE OPINION. 21 January 2009

TRANSPARENCY COMMITTEE OPINION. 21 January 2009 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 January 2009 BRIDION 100 mg/ml, solution for injection Box containing 10 x 2 ml bottles, CIP: 573 553-9 Box containing

More information

Lecture 5 Skeletal muscle relaxants. Pharmacologic management of parkinsonism and other movement disorders.

Lecture 5 Skeletal muscle relaxants. Pharmacologic management of parkinsonism and other movement disorders. Lecture 5 Skeletal muscle relaxants. Pharmacologic management of parkinsonism and other movement disorders. I. SKELETAL MUSCLE RELAXANTS Skeletal muscle relaxants are pharmacologically active substances

More information

Pharmacology Second. - Contraction of detrusor muscle in the bladder.

Pharmacology Second. - Contraction of detrusor muscle in the bladder. Pharmacology Second 1) Which of the following is correct regarding the autonomic nervous system (ANS)? - Afferent neurons carry signals from the CNS to the effector organs. - The neurotransmitter at the

More information

MESTINON NAME OF THE MEDICINE. Description: Pharmacology: Pyridostigmine Bromide. CAS number:

MESTINON NAME OF THE MEDICINE. Description: Pharmacology: Pyridostigmine Bromide. CAS number: MESTINON NAME OF THE MEDICINE Pyridostigmine Bromide. C9H13BrN2O2 CAS number: 101-26-8 Description: Mestinon contains, as active substance, pyridostigmine bromide, chemically described as the dimethylcarbamic

More information

FOR REPRESENTATIVE EDUCATION

FOR REPRESENTATIVE EDUCATION Neuromuscular Blockade in the ICU NIMBEX Indication 1 NIMBEX (cisatracurium besylate) is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients

More information

08-15 NORCURON ORGANON

08-15 NORCURON ORGANON 08-15 NORCURON ORGANON 1. NAME OF THE MEDICINAL PRODUCT Norcuron 4 mg, powder for solution for injection Norcuron 10 mg, powder for solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Norcuron

More information

Laith Mohammed Abbas Al-Huseini. M.B.Ch.B., M.Sc, M.Res, Ph.D. Department of Pharmacology and Therapeutics

Laith Mohammed Abbas Al-Huseini. M.B.Ch.B., M.Sc, M.Res, Ph.D. Department of Pharmacology and Therapeutics Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics I. Pre-anesthesia evaluation and preparation II. Pre-anesthesia medication III. Anesthesia steps:

More information

Tips for Drug Learning. Edward JN Ishac, Ph.D. ANS Review Core Concepts. Neurons of the ANS. Transmitter synthesis and release

Tips for Drug Learning. Edward JN Ishac, Ph.D. ANS Review Core Concepts. Neurons of the ANS. Transmitter synthesis and release Autonomic Nervous System & Neuromuscular Junction Review 2007 Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 8-2127 8-2126 Department of Pharmacology and Toxicology Medical College of Virginia

More information

Core Safety Profile. Pharmaceutical form(s)/strength: 5mg/ml and 25 mg/ml, Solution for injection, IM/IV FI/H/PSUR/0010/002 Date of FAR:

Core Safety Profile. Pharmaceutical form(s)/strength: 5mg/ml and 25 mg/ml, Solution for injection, IM/IV FI/H/PSUR/0010/002 Date of FAR: Core Safety Profile Active substance: Esketamine Pharmaceutical form(s)/strength: 5mg/ml and 25 mg/ml, Solution for injection, IM/IV P-RMS: FI/H/PSUR/0010/002 Date of FAR: 29.05.2012 4.3 Contraindications

More information

General anesthesia. No single drug capable of achieving these effects both safely and effectively.

General anesthesia. No single drug capable of achieving these effects both safely and effectively. General anesthesia General anesthesia is essential to surgical practice, because it renders patients analgesic, amnesia, and unconscious reflexes, while causing muscle relaxation and suppression of undesirable

More information

Nervous and chemical regulation heart

Nervous and chemical regulation heart Nervous and chemical regulation heart Myogenic heart when separated out from the body keep on beating on their own but when in the body the rate of heart beat is modified through various stimuli such as

More information

למידע נוסף ניתן לעיין בעלון לרופא באתר משרד הבריאות או ליצור קשר טלפוני בטלפון

למידע נוסף ניתן לעיין בעלון לרופא באתר משרד הבריאות או ליצור קשר טלפוני בטלפון חברת פרמה מדיס שמחה לבשר על תחילת שיווקו של תכשיר חדש. שם התכשיר: NEOSTIGMINE - HAMELN 2.5 MG/ML INJECTION צורת מינון: SOLUTION FOR INJECTION דרך מתן: I.M, I.V, S.C הרכב )חומר פעיל(: NEOSTIGMINE METHYLSULFATE

More information

EVALUATION OF ATRACURIUM BESYLATE AND VECURONIUM BROMIDE IN COMBINATION TO FACILITATE RAPID TRACHEAL INTUBATION

EVALUATION OF ATRACURIUM BESYLATE AND VECURONIUM BROMIDE IN COMBINATION TO FACILITATE RAPID TRACHEAL INTUBATION Original Article EVALUATION OF ATRACURIUM BESYLATE AND VECURONIUM BROMIDE IN COMBINATION TO FACILITATE RAPID TRACHEAL INTUBATION Kiran B Patel 1, Ananyaruchi S Sharma 2, Hitesh S Patel 2, Rahul D Patel

More information

Definition of synapse:

Definition of synapse: Definition of synapse: A junctional connection between two neurons, across which a signal can pass Pre-synaptic neuron: Where a neurotransmitter is synthesized, stored and released upon cell activation.

More information

13.01 INHALATIONAL & IV ANAESTHETICS

13.01 INHALATIONAL & IV ANAESTHETICS 13 ANAESTHETICS 13.01 INHALATIONAL & IV ANAESTHETICS Halothane (Fluothane) 250ml Isoflurane (Forane) 250ml *Ketamine (as HCl) Inj 50mg/ml, 10ml (Ketalar) *Nitrous Oxide Inhalation Gas [Cylinder neck: colour

More information

Anticholinesterases and anticholinergic drugs

Anticholinesterases and anticholinergic drugs Anticholinesterases and anticholinergic drugs V Priya Nair MB BS FRCA Jennifer M Hunter MB CHB PHD FRCA Key points There are two types of cholinesterase: acetylcholinesterase in the neuromuscular junction

More information

Cholinoceptor - Activating &Cholinesterase-Inhibiting Drugs

Cholinoceptor - Activating &Cholinesterase-Inhibiting Drugs Cholinoceptor - Activating &Cholinesterase-Inhibiting Drugs Choline Ester ACE Muscarinic Nicotinic Acetylcholine ++++ +++ +++ Methacholine + ++++ None Carbachol Negligible ++ +++ Bethanechol Negligible

More information

Comparative study of Succinylcholine, Rocuronium and Vecuronium for intubation and hemodynamic changes during general anaesthesia

Comparative study of Succinylcholine, Rocuronium and Vecuronium for intubation and hemodynamic changes during general anaesthesia IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 10 Ver. I (October. 2016), PP 14-19 www.iosrjournals.org Comparative study of Succinylcholine,

More information

Neurology. Brain death. Tests. EEG in Monitoring 3.B.2. Neuromuscular disorders and anaesthesia. Neurology 3.C.6.1 James Mitchell (December 24, 2003)

Neurology. Brain death. Tests. EEG in Monitoring 3.B.2. Neuromuscular disorders and anaesthesia. Neurology 3.C.6.1 James Mitchell (December 24, 2003) Neurology Brain death Tests EEG in Monitoring 3.B.2 Neuromuscular disorders and anaesthesia Neurology 3.C.6.1 James Mitchell (December 24, 2003) Brain death Coma GCS < 8, potential for recovery Persistent

More information

SOMATIC AND AUTONOMIC UPREGULATION IN THE QUADRIPLEGIC PATIENT

SOMATIC AND AUTONOMIC UPREGULATION IN THE QUADRIPLEGIC PATIENT EDITORIAL SOMATIC AND AUTONOMIC UPREGULATION IN THE QUADRIPLEGIC PATIENT Patients with chronic spinal cord transection develop both somatic and autonomic denervation below the level of denervation. This

More information

NEUROMUSCULAR BLOCKING AGENTS AND MUSCLE RELAXANTS

NEUROMUSCULAR BLOCKING AGENTS AND MUSCLE RELAXANTS NEUROMUSCULAR BLOCKING AGENTS AND MUSCLE RELAXANTS Drugs that effect skeletal muscle function: 1. Neuromuscular blockers- used in surgical procedures to cause muscle paralysis 2. Centrally acting muscle

More information

Autonomic Nervous System & Neuromuscular Junction Review

Autonomic Nervous System & Neuromuscular Junction Review Autonomic Nervous System & Neuromuscular Junction Review Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 8-2127 8-2126 Department of Pharmacology and Toxicology Medical College of Virginia

More information

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory TRACRIUM. Atracurium Besylate Injection IP

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory TRACRIUM. Atracurium Besylate Injection IP For the use only of Registered Medical Practitioners or a Hospital or a Laboratory TRACRIUM Atracurium Besylate Injection IP QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains Atracurium Besylate

More information

Muscle Tissue. Muscle Tissue Outline. General Function of Muscle Tissue

Muscle Tissue. Muscle Tissue Outline. General Function of Muscle Tissue Muscle Tissue Muscle Tissue Outline General Functions of Muscle Tissue Characteristics of Muscle Tissue Classification of Muscle Tissue Skeletal Muscle Structure and Function Muscle Energetics Muscle Mechanics

More information

MUSCLE relaxants are used to provide better operating conditions for

MUSCLE relaxants are used to provide better operating conditions for CLEVELAND CLINIC QUARTERLY Copyright 1970 by The Cleveland Clinic Foundation Volume 37, July 1970 Printed in U.S.A. Pancuronium bromide A new non-depolarizing muscle relaxant Preliminary in fifty patients

More information

Dr. Hesham Aly Salem Dept. of Pharmacology & Toxicology F O P C U 2016

Dr. Hesham Aly Salem Dept. of Pharmacology & Toxicology F O P C U 2016 Dr. Hesham Aly Salem Dept. of Pharmacology & Toxicology F O P C U 2016 Release Acetylcholine (Ach) 1. All motor nerves leaving CNS: 1. All preganglionic fibers (sympathetic & parasympathetic) 2. Somatic

More information

Cholinergic Agonists & Antagonists

Cholinergic Agonists & Antagonists Cholinergic Agonists & Antagonists Course: Integrated Therapeutics I Professor: Judi Steinman, PhD Email: steinman@hawaii.edu Material covered on: Exam #1 Reading: Katzung 12 ed Chapter 7, 8, 9, 10 1 3

More information

Autonomic Nervous System

Autonomic Nervous System Autonomic Nervous System Touqeer Ahmed PhD 3 rd March, 2017 Atta-ur-Rahman School of Applied Biosciences National University of Sciences and Technology Nervous System Divisions The peripheral nervous system

More information

Autonomic Nervous System

Autonomic Nervous System Autonomic Nervous System 6 th March, 2015 & 19 th March, 2015 Touqeer Ahmed Ph.D. Atta-ur-Rahman School of Applied Biosciences National University of Sciences and Technology Autonomic Nervous System Role

More information

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh 12 Lujain Hamdan Ayman Musleh & Yahya Salem Mohammed khatatbeh the last lecture, we have studied the differences between the two divisions of the ANS: sympathetic and parasympathetic pathways which work

More information

Hemodynamic effects of muscle relaxants

Hemodynamic effects of muscle relaxants Hemodynamic effects of muscle relaxants Anis Baraka, M.D. Beirut, Lebanon The hemodynamic effects of neuromuscular blocking drugs (muscle relaxants) may be attributed to two basic mechanisms: (1) histamine

More information

PAEDIATRIC ANAESTHETIC EMERGENCIES PART I. Dr James Cockcroft, South West School of Anaesthesia. Dr Sarah Rawlinson, Derriford Hospital, Plymouth, UK

PAEDIATRIC ANAESTHETIC EMERGENCIES PART I. Dr James Cockcroft, South West School of Anaesthesia. Dr Sarah Rawlinson, Derriford Hospital, Plymouth, UK PAEDIATRIC ANAESTHETIC EMERGENCIES PART I Original Article by: Dr Claire Todd, South West School of Anaesthesia Dr James Cockcroft, South West School of Anaesthesia Dr Sarah Rawlinson, Derriford Hospital,

More information

Edward JN Ishac, Ph.D. Tips for Drug Learning

Edward JN Ishac, Ph.D. Tips for Drug Learning Autonomic Nervous System & Neuromuscular Junction Review 2008 Edward JN Ishac, Ph.D. Smith Building, Room 742 eishac@vcu.edu 8-2127 8-2126 Department of Pharmacology and Toxicology Medical College of Virginia

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET NEW ZEALAND DATA SHEET VECURE 1. Product Name VECURE 10 mg, powder for injection. 2. Qualitative and Quantitative Composition VECURE 10 mg, 1 vial contains 10 mg vecuronium bromide. When reconstituted

More information

Comparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases)

Comparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases) ISPUB.COM The Internet Journal of Anesthesiology Volume 20 Number 1 Comparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases) K Bhati, V Parmar Citation K Bhati,

More information

PRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN

PRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN British Journal of Anaesthesia 1990; 64: 577-581 PRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN C. E. SMITH, J.

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

2 QUALITATIVE AND QUANTITATIVE COMPOSITION AUSTRALIAN PRODUCT INFORMATION NEOSTIGMINE INJECTION BP (NEOSTIGMINE METHYLSULFATE) 1 NAME OF THE MEDICINE Neostigmine methylsulfate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml sterile solution of

More information